Skip to main content

NDMA Contamination Leads To Another Recall

NDMA Contamination Leads To Another Recall

NDMA Contamination Leads To Another Recall

Introduction

The latest drug to undergo recall due to high levels of the cancer-causing chemical N-Nitrosodimethylamine (NDMA) is metformin, a medication used to control high blood sugar in type-2 diabetes patients.

The Food and Drug Administration (FDA) asked five unidentified drug manufacturers to voluntarily recall the widely used diabetes drug. The federal regulators also issued a metformin NDMA alert to the patients and healthcare professionals, warning about the presence of the toxic chemical in a higher-than-acceptable level that could potentially cause cancer.

The recall was the result of a citizen’s petition filed by the independent online pharmacy Valisure, who urged the FDA to issue metformin recalls in March 2020, after finding high levels of NDMA during independent testing. The FDA confirmed findings on some lots that Valisure had raised concerns about, and not all of them were agreed.

Lately, popular heartburn drug Zantac and blood pressure medication Valsartan also faced a widespread recall post the detection of the toxic chemical. The users of both drugs have reported developing various types of cancers following long-term use, including breast cancer, bladder cancer, stomach cancer, testicular cancer, and other injuries.

More than 230 Zantac lawsuits are pending in the Southern District of Florida. The lawsuits are consolidated and centralized before U.S. District Judge Robin L in Florida under MDL No: 2924, for coordinated discovery and pretrial proceedings.

Nearly 130 product liability lawsuits and class action claims involving Valsartan are currently pending in the federal court system. Valsartan claims are consolidated under MDL No. 2875 in the United States District Court, District of New Jersey, presided by Judge Robert B. Kugler, U.S.D.J, and Hon. Joel Schneider, U.S.M.J.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Purdue, Sacklers Agree to New $7.4B Opioid Settlement

Categories: Opioids

All 50 U.S. states, along with the District of Columbia and U.S. territories, have agreed to a $7.4 billion settlement with Purdue Pharma, the manufacturer of OxyContin.

This deal addresses allegations that the company’s aggressive and…

Oregon to Get $66M in Sackler Opioid Settlement

Categories: Opioids

Oregon will gain $66 million as part of a nationwide settlement with the Sackler family and Purdue Pharma, the makers of OxyContin. The funds will be used to expand and…

Study Finds Toxic Metals in E-Cigs and U-Cigs Vapors

Categories: E-Cigarette: JUUL

As health concerns about e-cigarette use escalate, emerging research suggests that a newer class of vaping products—ultrasonic cigarettes or u-cigarettes—may pose even greater risks.

A study published in Environmental Health Perspectives in…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!